WHO and partners launch compensation program for adverse effects of vaccination

The World Health Organization (WHO) and its partners have agreed to launch a program for claims for serious side effects of inhabitants of the 92 poorest countries caused by the
Vaccination against COVID-19, the WHO said today in a statement.

« This is the first and only global compensation mechanism for vaccination injuries » that operates internationally, the WHO said in a statement.

According to the WHO, the No-Fault Compensation program will offer eligible individuals « a fast, fair, robust and transparent process to receive compensation for serious but rare adverse events associated with vaccines distributed by COVAX. until June 30, 2022 « .

COVAX is a WHO-led mechanism for better distribution of COVID-19 vaccines. The statement indicated that all vaccines purchased or distributed through COVAX receive regulatory approval or authorization for emergency use to confirm their safety and efficacy.

« But, as with all drugs, even vaccines that are approved for general use could, in rare cases, cause serious adverse reactions, » the WHO said.

« By providing a lump sum no-fault compensation for the full and final settlement of any claim, the COVAX program seeks to significantly reduce the need for going to court, a potentially time-consuming and costly process, » the statement said.

By providing a mechanism to resolve serious adverse events, the compensation program will be able to help those who may suffer such effects and help manufacturers deliver vaccines to countries more quickly, said Seth Berkley, director of the Alliance for Vaccination Gavi, in the statement.

The program will be operated by ESIS, a subsidiary of Zurich-based multinational insurer Chubb Limited, the WHO said, adding that the compensation mechanism will be financed by Gavi through « a fee applied to all doses of vaccines against the COVID-19 distributed through the COVAX Mechanism « .

WHO Director General Tedros Adhanom Ghebreyesus praised the deal, saying it offers more protection and confidence in the power of vaccines to save lives.

As the world struggles to contain the pandemic, the Vaccination is underway in many countries that already have licensed coronavirus vaccines.

On the other hand, 251 vaccine candidates are still in development worldwide, of which 70 are in clinical trials, in countries such as Germany, China, Russia, the United Kingdom and the United States, according to information published by the World Organization of the Health on February 19.


Coronavirus in the world today: all the information


Coronavirus in Argentina: All the information about the pandemic throughout the country


Coronavirus vaccine: progress in the race to combat covid-19

Xinhua Source